Procept BioRobotics [PRCT] vs Globus Medical [GMED] Detailed Stock Comparison

Procept BioRobotics

NASDAQ

Globus Medical

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Procept BioRobotics wins in 4 metrics, Globus Medical wins in 14 metrics, with 0 ties. Globus Medical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Procept BioRobotics	Globus Medical	Better
P/E Ratio (TTM)	-21.95	43.77	Procept BioRobotics
Price-to-Book Ratio	5.52	1.84	Globus Medical
Debt-to-Equity Ratio	20.57	2.83	Globus Medical
PEG Ratio	-28.88	17.15	Procept BioRobotics
EV/EBITDA	-22.16	10.62	Procept BioRobotics
Profit Margin (TTM)	-30.60%	13.58%	Globus Medical
Operating Margin (TTM)	-28.02%	17.33%	Globus Medical
EBITDA Margin (TTM)	N/A	17.33%	N/A
Return on Equity	-26.40%	8.62%	Globus Medical
Return on Assets (TTM)	-12.93%	5.82%	Globus Medical
Free Cash Flow (TTM)	$-103.62M	$405.21M	Globus Medical
Dividend Yield	0.64%	N/A	N/A
1-Year Return	-37.17%	-19.88%	Globus Medical
Price-to-Sales Ratio (TTM)	7.77	3.02	Globus Medical
Enterprise Value	$1.91B	$7.81B	Globus Medical
EV/Revenue Ratio	6.93	2.98	Globus Medical
Gross Profit Margin (TTM)	63.85%	67.33%	Globus Medical
Revenue per Share (TTM)	$5	$19	Globus Medical
Earnings per Share (Diluted)	$-1.54	$1.34	Globus Medical
Beta (Stock Volatility)	1.04	1.20	Procept BioRobotics

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Procept BioRobotics vs Globus Medical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Procept BioRobotics	-2.98%	-23.12%	-33.67%	-29.92%	-44.93%	-53.81%
Globus Medical	8.47%	11.42%	3.62%	-19.06%	-32.88%	-28.33%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Procept BioRobotics	-37.17%	-12.19%	-3.98%	-3.98%	-3.98%	-3.98%
Globus Medical	-19.88%	-12.03%	6.93%	121.15%	334.44%	334.44%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Procept BioRobotics (PRCT): View Full Stock Overview

Globus Medical (GMED): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Procept BioRobotics vs Globus Medical

Metric	PRCT	GMED
Market Information
Market Cap i	$2.14B	$7.92B
Market Cap Category	Mid cap	Mid cap
10 Day Avg. Volume i	1,786,940	1,536,240
90 Day Avg. Volume i	1,285,823	1,652,257
Last Close	$38.41	$58.65
52 Week Range	$37.12 - $103.81	$51.79 - $94.93
% from 52W High	-63.00%	-38.22%
All-Time High	$103.81 (Nov 11, 2024)	$94.93 (Jan 27, 2025)
% from All-Time High	-63.00%	-38.22%
Growth Metrics
Quarterly Revenue Growth	0.48%	0.18%
Quarterly Earnings Growth	0.55%	5.39%
Financial Health
Profit Margin (TTM) i	-0.31%	0.14%
Operating Margin (TTM) i	-0.28%	0.17%
Return on Equity (TTM) i	-0.26%	0.09%
Debt to Equity (MRQ) i	20.57	2.83
Cash & Liquidity
Book Value per Share (MRQ)	$6.96	$31.81
Cash per Share (MRQ)	$5.46	$1.70
Operating Cash Flow (TTM) i	$-103,623,000	$669.16M
Levered Free Cash Flow (TTM) i	$-91,413,000	$456.11M
Dividends
Last 12-Month Dividend Yield i	0.64%	N/A
Last 12-Month Dividend i	$0.38	N/A

Valuation & Enterprise Metrics Analysis: Procept BioRobotics vs Globus Medical

Metric	PRCT	GMED
Price Ratios
P/E Ratio (TTM) i	-21.95	43.77
Forward P/E i	-28.88	17.15
PEG Ratio i	-28.88	17.15
Price to Sales (TTM) i	7.77	3.02
Price to Book (MRQ) i	5.52	1.84
Market Capitalization
Market Capitalization i	$2.14B	$7.92B
Enterprise Value i	$1.91B	$7.81B
Enterprise Value Metrics
Enterprise to Revenue i	6.93	2.98
Enterprise to EBITDA i	-22.16	10.62
Risk & Other Metrics
Beta i	1.04	1.20
Book Value per Share (MRQ) i	$6.96	$31.81

Financial Statements Comparison: Procept BioRobotics vs Globus Medical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	PRCT	GMED
Revenue/Sales i	$69.16M	$598.12M
Cost of Goods Sold i	$25.00M	$195.40M
Gross Profit i	$44.16M	$402.72M
Research & Development i	$16.40M	$33.06M
Operating Income (EBIT) i	$-27.44M	$98.06M
EBITDA i	$-22.39M	$160.92M
Pre-Tax Income i	$-24.74M	$103.67M
Income Tax i	N/A	$28.21M
Net Income (Profit) i	$-24.74M	$75.46M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	PRCT	GMED
Cash & Equivalents i	$316.21M	$461.27M
Total Current Assets i	$465.79M	$1.71B
Total Current Liabilities i	$52.06M	$384.70M
Long-Term Debt i	$77.83M	$81.69M
Total Shareholders Equity i	$389.16M	$4.09B
Retained Earnings i	$-570.72M	$1.04B
Property, Plant & Equipment i	$21.26M	$1.06B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	PRCT	GMED
Operating Cash Flow i	$-11.65M	$193.84M
Capital Expenditures i	$-1.84M	$-36.10M
Free Cash Flow i	$-18.82M	$136.20M
Debt Repayment i	N/A	$-449.99M
Common Stock Repurchase i	N/A	$-190.45M

Short Interest & Institutional Ownership Analysis

Metric	PRCT	GMED
Shares Short i	6.82M	4.52M
Short Ratio i	9.53	3.01
Short % of Float i	0.15%	0.04%
Average Daily Volume (10 Day) i	1,786,940	1,536,240
Average Daily Volume (90 Day) i	1,285,823	1,652,257
Shares Outstanding i	54.72M	137.42M
Float Shares i	53.32M	111.79M
% Held by Insiders i	0.04%	0.01%
% Held by Institutions i	0.96%	1.02%

Dividend Analysis & Yield Comparison: Procept BioRobotics vs Globus Medical

Metric	PRCT	GMED
Last 12-Month Dividend i	$0.38	N/A
Last 12-Month Dividend Yield i	0.64%	N/A
3-Year Avg Annual Dividend i	$0.53	N/A
3-Year Avg Dividend Yield i	0.12%	N/A
3-Year Total Dividends i	$1.59	N/A
Ex-Dividend Date	Mar 31, 2025	N/A

Procept BioRobotics [PRCT] vs Globus Medical [GMED] Detailed Stock Comparison